1492 Capital Management LLC Invests $1.25 Million in Novanta Inc. $NOVT

1492 Capital Management LLC purchased a new position in shares of Novanta Inc. (NASDAQ:NOVT) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 10,506 shares of the technology company’s stock, valued at approximately $1,250,000.

Several other hedge funds also recently modified their holdings of NOVT. Goldman Sachs Group Inc. grew its stake in Novanta by 42.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 483,533 shares of the technology company’s stock valued at $57,536,000 after buying an additional 143,508 shares during the last quarter. Natixis Advisors LLC grew its stake in Novanta by 159.9% in the 4th quarter. Natixis Advisors LLC now owns 37,921 shares of the technology company’s stock valued at $4,512,000 after buying an additional 23,332 shares during the last quarter. Mawer Investment Management Ltd. grew its stake in Novanta by 16.9% in the 4th quarter. Mawer Investment Management Ltd. now owns 457,160 shares of the technology company’s stock valued at $54,397,000 after buying an additional 66,012 shares during the last quarter. Norges Bank acquired a new position in Novanta in the 4th quarter valued at $50,719,000. Finally, Madison Wealth Partners Inc acquired a new position in Novanta in the 4th quarter valued at $236,000. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Price Performance

Shares of Novanta stock opened at $166.94 on Thursday. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69. Novanta Inc. has a fifty-two week low of $98.27 and a fifty-two week high of $171.85. The firm has a fifty day moving average price of $137.00 and a two-hundred day moving average price of $130.02. The company has a market cap of $5.94 billion, a PE ratio of 120.97 and a beta of 1.68.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings results on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.03. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The firm had revenue of $257.71 million during the quarter, compared to the consensus estimate of $253.40 million. During the same period in the prior year, the firm earned $0.74 EPS. The business’s revenue was up 10.4% on a year-over-year basis. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Analysts expect that Novanta Inc. will post 3.59 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on NOVT. Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a research note on Friday, April 17th. Wall Street Zen downgraded shares of Novanta from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Finally, Robert W. Baird increased their price target on shares of Novanta from $144.00 to $173.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $173.00.

Insider Activity

In other Novanta news, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total value of $1,128,225.00. Following the completion of the sale, the chief executive officer owned 42,761 shares in the company, valued at approximately $6,432,537.23. This trade represents a 14.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Buckley sold 9,957 shares of the firm’s stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $116.77, for a total transaction of $1,162,678.89. Following the completion of the sale, the chief financial officer owned 96,616 shares of the company’s stock, valued at $11,281,850.32. The trade was a 9.34% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 23,957 shares of company stock valued at $3,136,229 in the last 90 days. Corporate insiders own 1.20% of the company’s stock.

Novanta Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.